Oct 3rd, 2022 - HealthDay News — There is an association between vaccine-associated aluminum and persistent asthma among children with and without eczema, according to a study published online in Academic Pediatrics. Matthew F. Daley, MD, from Kaiser Permanente Colorado in Aurora, and colleagues conducted a retrospective cohort study in the Vaccine Safety Datalink to examine the association between cumulative ...

Oct 3rd, 2022 - In patients with rheumatoid arthritis (RA)/psoriatic arthritis (PsA), holding vs continuing methotrexate (MTX) after the second dose of the ChAdOx1 nCov-19 (Oxford-AstraZeneca) vaccine results in a higher antibody response, according to the results of a study published in The Lancet Rheumatology. The researchers sought to evaluate the impact of holding MTX for 2 weeks after each dose of the COV...

Oct 3rd, 2022 - Caused by the same family of viruses (Poxviridae) as the variola virus, monkeypox was discovered in 1958 after outbreaks occurred among research monkeys. It was first identified in humans in 1970. Before the 2022 outbreak, nearly all cases seen outside Africa were linked to the continent via travel or animal export. However, data suggest that men who have sex with men (MSM) account for a sizeab...

Oct 3rd, 2022 - (Reuters) - Moderna Inc has refused to hand over to China the core intellectual property behind the development of its COVID-19 vaccine, leading to a collapse in negotiations on its sale there, the Financial Times reported on Saturday, citing people familiar with the matter. The Cambridge, Massachusetts-based pharmaceutical company turned down China’s request to hand over the recipe for its mRN...

Oct 3rd, 2022 - Men who have sex with men (MSM) living with HIV, especially those who are young or who've had gonorrhea should get the human papillomavirus (HPV) 9-valent vaccine (Gardasil 9), findings of a newly published study in JAIDS suggests. According to the World Health Organization, only 30% of the target population worldwide has received the HPV vaccine. Despite increased risk for HPV anal infection (...

Oct 3rd, 2022 - Are nasal sprays the future of COVID-19 vaccines? That’s certainly the hope of many researchers working on new kinds of inoculation. Nasal vaccines were recently approved in China and India for use as a booster dose. The Chinese vaccine is inhaled through the mouth and nose, whereas the Indian vaccine is delivered through nasal drops. These vaccines are just two of more than 100 oral or nasal v...

Oct 3rd, 2022 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Throughout the Covid-19 pandemic, the U.S. federal government has supervised the purchasing and distribution of vaccines, tests, and treatments. Many Americans saw for the first time what publicly funded healthcare could do as citizens were able to access prevention and treatment without for-pro...

Sep 30th, 2022 - More than 1100 wildfires burned in the US during the month of September, according to the Fire, Weather, and Avalanche Center1 — a situation that, according to research, causes more people with asthma, other respiratory issues, and heart conditions to show up at doctors’ offices, emergency departments, and hospitals. The particulate matter generated by wildfires is especially hazardous for chil...

Sep 30th, 2022 - Vaccination against COVID-19 was not found to increase incidence of disease flares in patients with systemic lupus erythematosus (SLE) compared with those who were unvaccinated, according to study findings published in Vaccine. Researchers at the Department of Medicine at Tuen Mun Hospital in Hong Kong conducted a retrospective study to analyze patterns of vaccine hesitancy, vaccination status,...

Sep 30th, 2022 - Prolonged COVID-19 symptom duration was assessed in patients with systemic autoimmune rheumatic diseases (SARDs), in a study published in RMD Open. While the majority of patients with SARDs had complete symptom resolution by day 15 after COVID-19 onset, some reported symptoms that persisted for at least 28 days, with 1 in 10 experiencing symptoms for at least 90 days. Researchers analyzed data ...

Sep 30th, 2022 - Ambulatory COVID-19 is associated with a substantial increase in excess venous thromboembolism (VTE), which is substantially higher among unvaccinated individuals, and increases with older age, in men, and in patients with obesity. These are the findings of a retrospective study published in JAMA Internal Medicine. Researchers conducted a population-based cohort study to explore the clinical an...

Sep 30th, 2022 - The Future of Epidemics It seems like one epidemic after another is in the news these days. But are there really more of them? Short answer: yes. Emerging, reemerging diseases: Some diseases have appeared in recent years for the first time; some are old ones that are resurging. New vectors include SARS-CoV-1, SARS-CoV-2, and H1N1. Transmitted from animals to humans, these viruses initially appe...

Sep 30th, 2022 - Before COVID-19 vaccines were widely available, one of the most common and serious manifestations of SARS-CoV-2 infection was pneumonia. Therefore, it is logical to ask whether the COVID-19 pandemic has played a role in the increase in Spain in the number of cases of pneumococcal disease caused by antibiotic-resistant strains. The instinctual response is that there should be no relationship, si...

Sep 30th, 2022 - JAKARTA/BEIJING (Reuters) - Indonesia said it has granted emergency use approval to an mRNA COVID-19 vaccine developed by a Chinese company, becoming the first country, ahead of even China, to do so. Indonesia's food and drugs agency (BPOM) greenlighted the use of Walvax Biotechnology Co Ltd's mRNA vaccine, which has been in development for more than two years and targets the original strain of...

Sep 30th, 2022 - (Reuters) — Around 3.2 million people in the United States received updated COVID-19 booster shots over the past week, the Centers for Disease Control and Prevention said on Thursday. The CDC said a total of 7.6 million Americans had received the shot as of Sept. 28, the first four weeks the booster has been available. This is up from the 4.4. million people who received the shot as of Sept. 21...

Sep 30th, 2022 - ROME (Reuters) -Italians will no longer have to wear face masks on public transport, the health ministry said late on Thursday, in the latest easing of rules against the coronavirus pandemic. The ministry said a decree requiring mask wearing on trains, buses and ferries, expiring on Friday, would not be renewed. The obligation was extended, however, for hospitals and care homes. Italy is one of...

Sep 30th, 2022 - SHANGHAI (Reuters) — For most of China's 1.4 billion people, regular COVID-19 tests have become a way of life. Siyuan Zhuji is trying to turn them into a work of art. Since March, the 33-year-old multi-disciplinary artist from Jiangsu province has been filming his own nucleic acid tests with a small camera in his mouth. His video clips show teeth and tongue and an approaching cotton bud. In som...

Sep 30th, 2022 - HONG KONG (Reuters) - The Hong Kong government said on Friday it aims to ease some coronavirus curbs in an orderly way as pandemic trends in the Asia financial hub were continuing to stabilize. From Oct. 6, some social distancing measures will be relaxed including raising the maximum number of persons per table in restaurants to 12 from eight, while banquets will be allowed to have up to 240 pe...

Sep 30th, 2022 - STOCKHOLM, Sweden — Enterovirus infection appears to be strongly linked to both type 1 diabetes and islet cell autoantibodies, new research suggests. The strength of the relationship, particularly within the first month of type 1 diabetes diagnosis, "further supports the rationale for development of enterovirus-targeted vaccines and antiviral therapy to prevent and reduce the impact of type 1 d...

Sep 29th, 2022 - Pfizer and BioNTech have completed a submission to the Food and Drug Administration (FDA) requesting Emergency Use Authorization (EUA) for a 10-µg booster dose of the Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine for children 5 to 11 years of age. In August 2022, the FDA authorized the Pfizer-BioNTech COVID-19 Vaccine, Bivalent for use as a single booster dose in individuals 12 years of a...